In another mouse model of PD, local injection of ASOs against SNCA mRNA into the striatum significantly reduced endogenous α-syn levels, thereby preventing and inhibiting the spread of phosphorylated α-syn pathologies throughout the brain, including the contralateral hemisphere. The gene discussed is SNCA; the disease is Parkinson disease.